Biocartis Revenue and Competitors
Estimated Revenue & Valuation
- Biocartis's estimated annual revenue is currently $107.7M per year.
- Biocartis's estimated revenue per employee is $251,000
Employee Data
- Biocartis has 429 Employees.
- Biocartis grew their employee count by -17% last year.
Biocartis's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Contract Manufacturing | Reveal Email/Phone |
3 | Head ICT | Reveal Email/Phone |
4 | Data Scientist | Reveal Email/Phone |
5 | Director - US Customer Service & Support | Reveal Email/Phone |
6 | Director Clinical Programs | Reveal Email/Phone |
7 | Chief Technology Officer | Reveal Email/Phone |
8 | Director - US Customer Service & Support | Reveal Email/Phone |
9 | Director Human Resources | Reveal Email/Phone |
10 | Chief Scientific Officer | Reveal Email/Phone |
Biocartis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $17.1M | 68 | -4% | N/A | N/A |
#2 | $26.9M | 107 | 8% | N/A | N/A |
#3 | $24.8M | 99 | 5% | N/A | N/A |
#4 | $19.1M | 76 | 0% | N/A | N/A |
#5 | $30.4M | 121 | 4% | N/A | N/A |
#6 | $74.3M | 296 | N/A | N/A | N/A |
#7 | $40.2M | 160 | 5% | N/A | N/A |
#8 | $74M | 295 | 30% | N/A | N/A |
#9 | $420.2M | 1674 | 8% | N/A | N/A |
#10 | $51.5M | 205 | 1% | N/A | N/A |
What Is Biocartis?
Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. The Company's proprietary MDx Idyllaâ„¢ platform is a fully automated, real time system which offers accurate, highly-reliable molecular information from any biological sample in virtually any setting. Idyllaâ„¢ addresses the growing demand for personalized medicine by allowing fast and effective treatment selection and treatment progress monitoring. Biocartis is developing and marketing a rapidly expanding test menu addressing key unmet clinical needs in oncology and infectious diseases. These areas represent respectively the fastest and largest growing segments of the US$5 billion MDx market which is expected to grow to approximately US$8 billion in 2018. Biocartis employs approximately 300 people and is headquartered in Mechelen, Belgium. Further information can be found at: www.biocartis.com Molecular Diagnostics Solutions, Oncology, Infectious Diseases
keywords:N/A
N/A
Total Funding
429
Number of Employees
$107.7M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Biocartis News
Biocartis Announces Presentation of Three Idylla Studies at 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID).
Biocartis Announces Presentation of First Prospective Validation Study Data of Merlin Test by Partner SkylineDx at EADO 2022 Conference.
Mechelen, Belgium, 21 April 2022 Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company (Euronext...
PRESS RELEASE: REGULATED INFORMATION 10 November 2021, 07:00 CET BIOCARTIS Q3 2021 BUSINESS UPDATE Mechelen, Belgium, 10 November 2021 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today provides a business update f ...
Biocartis, located in the Intercity Business Park Mechelen, expands its existing office of 717m² with an adjacent office of 783m². Thanks to a turnkey solution, the new office was fitted out according to the "New Way of Working", which Biocartis believes in and invests in. This is already the fo ...
Other Companies in Belgravia
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $116.6M | 444 | 7% | N/A |
#2 | $172.7M | 453 | 5% | N/A |
#3 | $158.3M | 517 | 2% | N/A |
#4 | $213.7M | 518 | -29% | N/A |
#5 | $113.4M | 564 | 1% | N/A |